About Diagnostics (NASDAQ:CODX)
Co-Diagnostics, Inc., a molecular diagnostics company, intends to manufacture and sell reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules. It also intends to sell diagnostic equipment from other manufacturers as self-contained lab systems. Co-Diagnostics, Inc. was founded in 2013 and is headquartered in Salt Lake City, Utah.
Industry, Sector and Symbol
Industry Diagnostics & Research
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:CODX
CUSIPN/A
Phone+1-801-2789769
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins-149,750.40%
Return on Equity-3,935.44%
Return on Assets-479.06%
Miscellaneous
EmployeesN/A
Outstanding Shares11,920,000
Diagnostics (NASDAQ:CODX) Frequently Asked Questions
What is Diagnostics' stock symbol?
Diagnostics trades on the NASDAQ under the ticker symbol "CODX."
Who are some of Diagnostics' key competitors?
Who are Diagnostics' key executives?
Diagnostics' management team includes the folowing people:
- Mr. Dwight H. Egan, CEO, Pres & Chairman (Age 63)
- Dr. Brent C. Satterfield Ph.D., Co-Founder, Chief Science Officer, CTO & Director (Age 41)
- Mr. Reed L. Benson Esq., CFO, Sec. & Gen. Counsel (Age 70)
When did Diagnostics IPO?
(CODX) raised $9 million in an initial public offering on Thursday, July 13th 2017. The company issued 1,300,000 shares at $6.35-$6.75 per share. WallachBeth Capital and Network 1 Securities served as the underwriters for the IPO.
Has Diagnostics been receiving favorable news coverage?
Media coverage about CODX stock has trended somewhat positive on Tuesday, Accern Sentiment Analysis reports. The research group identifies positive and negative media coverage by reviewing more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Diagnostics earned a daily sentiment score of 0.13 on Accern's scale. They also assigned media coverage about the company an impact score of 49.30 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company's share price in the next several days.
How do I buy shares of Diagnostics?
Shares of CODX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Diagnostics' stock price today?
One share of CODX stock can currently be purchased for approximately $1.98.
How big of a company is Diagnostics?
Diagnostics has a market capitalization of $26.78 million.
How can I contact Diagnostics?
Diagnostics' mailing address is 4049 S Highland Dr, SALT LAKE CITY, UT 84124-1664, United States. The company can be reached via phone at +1-801-2789769.
MarketBeat Community Rating for Diagnostics (CODX)
MarketBeat's community ratings are surveys of what our community members think about Diagnostics and other stocks. Vote "Outperform" if you believe CODX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CODX will underperform the S&P 500 over the long term. You may vote once every thirty days.
Diagnostics (NASDAQ:CODX) Analyst Ratings History
| Date | Brokerage | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
(Data available from 4/24/2016 forward)
Diagnostics (NASDAQ:CODX) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
Diagnostics (NASDAQ CODX) Insider Trading and Institutional Ownership History
Diagnostics (NASDAQ CODX) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 4/16/2018 | Brent Satterfield | Insider | Buy | 500 | $1.94 | $970.00 | |  |
(Data available from 1/1/2013 forward)
Diagnostics (NASDAQ CODX) News Headlines
| Source: |
|
| Date | Headline |
|---|
 | Co-Diagnostics CEO to Discuss Strategic Direction in a Lytham Partners’ Virtual Presentation and Fireside Chat Event on Thursday, April 19, 2018 at 2:00 pm ET
finance.yahoo.com - April 16 at 9:13 AM |
 | Brent Satterfield Buys 2,400 Shares of Co-Diagnostics Inc (CODX) Stock
www.americanbankingnews.com - April 10 at 7:12 PM |
| Co-Diagnostics Files Initial Annual Report on Form 10-K and Updates Corporate Developments
finance.yahoo.com - April 5 at 9:09 AM |
| Co-Diagnostics, Inc. Announces Construction Update at JV Manufacturing Facility in India
finance.yahoo.com - March 22 at 9:35 AM |
| Co-Diagnostics Inc Announces Positive Results from Co-Primers™ Technology in Multiplex Tests for SNP Detection
finance.yahoo.com - February 28 at 9:15 AM |
| Co-Diagnostics, Inc. Initiates Vector Control Program in Dominican Republic
finance.yahoo.com - January 30 at 9:40 AM |
| Co-Diagnostics Inc's Lock-Up Period Will End on January 8th (NASDAQ:CODX)
www.americanbankingnews.com - January 1 at 1:16 AM |
| Co-Diagnostics, Inc. Announces Sale of Molecular Diagnostic Tests, Including Zika Virus, to Major Caribbean Laboratory
finance.yahoo.com - December 12 at 9:21 AM |
 | TJR Coatings Inc. Announces the Entering into of a Share Purchase Agreement to Acquire all of the Shares of DNA Logix Canada Inc.
www.finanznachrichten.de - November 24 at 4:00 PM |
| How Does Co-Diagnostics Inc (CODX) Compare To The Healthcare Sector?
finance.yahoo.com - November 21 at 5:33 PM |
| Co-Diagnostics, Inc. Reports Q3 Financial Results and Updates Corporate Developments
finance.yahoo.com - November 16 at 12:59 PM |
| Co-Diagnostics, Inc. Products to Be Presented at Fair of Havana 2017
finance.yahoo.com - October 31 at 6:37 PM |
| Who Owns Co-Diagnostics Inc (CODX)?
finance.yahoo.com - October 20 at 6:51 PM |
| Co-Diagnostics, Inc. to Present Zika Tests to Dominican Republic Ministry of Health
finance.yahoo.com - October 16 at 6:10 PM |
| Co-Diagnostics, Inc. to Present at NewsMakers Conference 2017
finance.yahoo.com - September 7 at 5:28 PM |
 | Co-Diagnostics (CODX) to Sign Purchase Agreement with MEDCIS Pathlabs
www.streetinsider.com - September 6 at 5:25 PM |
| Co-Diagnostics, Inc. to Sign Purchase Agreement with MEDCIS Pathlabs
finance.yahoo.com - September 5 at 6:59 PM |
| Co-Diagnostics, Inc. (CODX)
finance.yahoo.com - August 27 at 9:51 PM |
| Co-Diagnostics, Inc. Strengthens Zika Customer Base in Caribbean Basin
finance.yahoo.com - August 24 at 5:32 PM |
| Co-Diagnostics, Inc. CEO to Present at 2017 SALSS
finance.yahoo.com - August 22 at 11:02 PM |
| Co-Diagnostics Inc's (CODX) Quiet Period Set To End on August 21st
www.americanbankingnews.com - August 14 at 1:20 AM |
| Co-Diagnostics, Inc. to Undergo ISO 13485:2016 Audit
finance.yahoo.com - August 10 at 6:41 PM |
| Co-Diagnostics, Inc. to Attend AACC 2017
finance.yahoo.com - August 2 at 6:12 PM |
| Co-Diagnostics, Inc. Announces Joint Venture in India
finance.yahoo.com - August 1 at 12:23 PM |
| Co-Diagnostics, Inc. Verifies Zika CoPrimer™ Test
finance.yahoo.com - August 1 at 12:23 PM |
| Co-Diagnostics (NASDAQ:CODX) to Raise $9 Million in IPO
www.americanbankingnews.com - July 8 at 10:20 AM |
Diagnostics (NASDAQ:CODX) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Diagnostics (NASDAQ:CODX) Income Statement, Balance Sheet and Cash Flow Statement
Diagnostics (NASDAQ CODX) Stock Chart for Tuesday, April, 24, 2018
Loading chart…
